Publisher
Springer Science and Business Media LLC
Subject
Cardiology and Cardiovascular Medicine,Hematology
Reference8 articles.
1. Usman A, Bliden KP, Cho A et al (2022) Metformin use in patients hospitalized with COVID-19: lower inflammation, oxidative stress, and thrombotic risk markers and better clinical outcomes. J Thromb Thrombolysis 53(2):363–371
2. Kow CS, Hasan SS (2021) Mortality risk with preadmission metformin use in patients with COVID-19 and diabetes: A meta-analysis. J Med Virol 93(2):695–697
3. Reis G, Dos Santos Moreira Silva EA, Medeiros Silva DC et al (2022) Effect of early treatment with metformin on risk of emergency care and hospitalization among patients with COVID-19: The TOGETHER randomized platform clinical trial. Lancet Reg Health Am 6:100142
4. Menegazzo L, Scattolini V, Cappellari R et al (2018) The antidiabetic drug metformin blunts NETosis in vitro and reduces circulating NETosis biomarkers in vivo. Acta Diabetol 55(6):593–601
5. Carmona-Rivera C, Zhang Y, Dobbs K et al (2022) Multicenter analysis of neutrophil extracellular trap dysregulation in adult and pediatric COVID-19.Preprint. medRxiv. ;2022.02.24.22271475.
Cited by
1 articles.
订阅此论文施引文献
订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献